TECHNOLOGY TO OPTIMIZE SCFVS FOR TARGETING THERAPEUTICS


Year of Award:
2005
Award Type:
R33
Project Number:
CA112070
RFA Number:
RFA-CA-05-003
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
FEDERSPIEL, MARK J
Other PI or Project Leader:
N/A
Institution:
MAYO CLINIC
Antibodies provide superior targeting capabilities to a variety of therapeutic agents. Several technologies have greatly facilitated the initial identification of a variety of antibody reagents, including scFv and Fab antibodies, with virtually any possib